Evgeniya Antonova

667 total citations
19 papers, 453 citations indexed

About

Evgeniya Antonova is a scholar working on Physiology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Evgeniya Antonova has authored 19 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Rheumatology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Evgeniya Antonova's work include Asthma and respiratory diseases (9 papers), Urticaria and Related Conditions (8 papers) and Autoimmune Bullous Skin Diseases (4 papers). Evgeniya Antonova is often cited by papers focused on Asthma and respiratory diseases (9 papers), Urticaria and Related Conditions (8 papers) and Autoimmune Bullous Skin Diseases (4 papers). Evgeniya Antonova collaborates with scholars based in United States, Switzerland and United Kingdom. Evgeniya Antonova's co-authors include Karina Raimundo, Theodore A. Omachi, Benjamin Trzaskoma, Michael S. Broder, Eunice Chang, Allen P. Kaplan, James L. Zazzali, Christopher S. Ambrose, Catherine Rycroft and Karin Rosén and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, BMC Public Health and Vaccine.

In The Last Decade

Evgeniya Antonova

19 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evgeniya Antonova United States	10	262	169	153	98	92	19	453
Denisa Ferastraoaru United States	11	50 0.2×	14 0.1×	11 0.1×	124 1.3×	32 0.3×	37	504
Charles Lambert United Kingdom	10	176 0.7×	26 0.2×	37 0.2×	30 0.3×	42 0.5×	13	298
Jan Konar Sweden	7	13 0.0×	115 0.7×	39 0.3×	21 0.2×	38 0.4×	14	363
Nutan Agarwal India	14	33 0.1×	24 0.1×	22 0.1×	15 0.2×	83 0.9×	37	514
Pankti Mehta India	10	117 0.4×	19 0.1×	7 0.0×	12 0.1×	135 1.5×	47	333
H. G. Taylor United Kingdom	12	345 1.3×	43 0.3×	13 0.1×	6 0.1×	45 0.5×	18	498
Anne Des Roches Canada	10	50 0.2×	5 0.0×	12 0.1×	75 0.8×	12 0.1×	30	431
J Barrier France	6	56 0.2×	15 0.1×	24 0.2×	11 0.1×	28 0.3×	38	312
Penélope Esther Palominos Brazil	12	208 0.8×	16 0.1×	9 0.1×	13 0.1×	32 0.3×	34	321
N. Santana Mexico	6	186 0.7×	23 0.1×	12 0.1×	11 0.1×	19 0.2×	8	329

Countries citing papers authored by Evgeniya Antonova

Since Specialization

Citations

This map shows the geographic impact of Evgeniya Antonova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeniya Antonova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeniya Antonova more than expected).

Fields of papers citing papers by Evgeniya Antonova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeniya Antonova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeniya Antonova. The network helps show where Evgeniya Antonova may publish in the future.

Co-authorship network of co-authors of Evgeniya Antonova

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeniya Antonova. A scholar is included among the top collaborators of Evgeniya Antonova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeniya Antonova. Evgeniya Antonova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Busse, William W., Allan T. Luskin, Robert S. Zeiger, et al.. (2017). Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). Journal of Allergy and Clinical Immunology. 139(2). AB8–AB8. 2 indexed citations

Teague, W. Gerald, et al.. (2017). Allergen Sensitization Is Associated with Increased Rates of Exacerbations, Oral Corticosteroid (OCS) Use, and Asthma-Related Healthcare Services in Children with Severe or Poorly Controlled Asthma. Journal of Allergy and Clinical Immunology. 139(2). AB205–AB205. 1 indexed citations

Luskin, Allan T., Evgeniya Antonova, Michael S. Broder, et al.. (2017). Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio. Journal of Managed Care & Specialty Pharmacy. 23(11). 1117–1124. 9 indexed citations

Finlay, A.Y., Allen P. Kaplan, Lisa A. Beck, et al.. (2017). Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria. Journal of the European Academy of Dermatology and Venereology. 31(10). 1715–1721. 35 indexed citations

Casale, Thomas B., et al.. (2017). Study Design, Baseline and Open-Label Results from XTEND-CIU: A Phase IV, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Omalizumab through 48 Weeks in Patients with Chronic Idiopathic Urticaria. Journal of Allergy and Clinical Immunology. 139(2). AB271–AB271. 2 indexed citations

Chipps, Bradley E., Robert S. Zeiger, Allan T. Luskin, et al.. (2017). Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO. Annals of Allergy Asthma & Immunology. 119(6). 524–532.e2. 23 indexed citations

Luskin, Allan T., William W. Busse, Thomas B. Casale, et al.. (2017). Clinically Significant Improvements in Asthma Patient-Reported Outcomes: Results from the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study. Journal of Allergy and Clinical Immunology. 139(2). AB9–AB9. 1 indexed citations

Antonova, Evgeniya, Benjamin Trzaskoma, Theodore A. Omachi, & Michael Schätz. (2016). Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab. Journal of Allergy and Clinical Immunology. 137(2). AB14–AB14. 4 indexed citations

Zazzali, James L., Allen P. Kaplan, Marcus Maurer, et al.. (2016). Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Annals of Allergy Asthma & Immunology. 117(4). 370–377.e1. 20 indexed citations

10.

Giménez‐Arnau, Ana M., Sheldon L. Spector, Evgeniya Antonova, et al.. (2016). Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies. Clinical and Translational Allergy. 6(1). 32–32. 25 indexed citations

11.

Luskin, Allan T., Evgeniya Antonova, Michael S. Broder, et al.. (2016). Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis. ClinicoEconomics and Outcomes Research. Volume 8. 641–648. 23 indexed citations

12.

Ledford, Dennis K., Michael S. Broder, Evgeniya Antonova, et al.. (2016). Corticosteroid-related toxicity in patients with chronic idiopathic urticaria‐chronic spontaneous urticaria. Allergy and Asthma Proceedings. 37(6). 458–465. 18 indexed citations

13.

Broder, Michael S., Karina Raimundo, Evgeniya Antonova, & Eunice Chang. (2015). Resource Use and Costs in an Insured Population of Patients with Chronic Idiopathic/Spontaneous Urticaria. American Journal of Clinical Dermatology. 16(4). 313–321. 47 indexed citations

14.

Kaplan, Allen P., Marta Ferrer, Jonathan A. Bernstein, et al.. (2015). Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. Journal of Allergy and Clinical Immunology. 137(2). 474–481. 132 indexed citations

15.

Kaplan, Allen P., Evgeniya Antonova, Benjamin Trzaskoma, et al.. (2015). Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL). Journal of Allergy and Clinical Immunology. 135(2). AB127–AB127. 1 indexed citations

16.

Antonova, Evgeniya, Christopher S. Ambrose, David M. Kern, et al.. (2014). Seasonal influenza vaccination trends from 2007–2011 in privately insured children and adults in the United States. Vaccine. 32(48). 6563–6568. 7 indexed citations

17.

Pitman, Richard, et al.. (2013). Cost-Effectiveness Comparison Of Quadrivalent Versus Trivalent Influenza Vaccines In The United States. Value in Health. 16(3). A90–A90. 1 indexed citations

18.

Antonova, Evgeniya, Catherine Rycroft, Christopher S. Ambrose, Terho Heikkinen, & Nicola Principi. (2012). Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health. 12(1). 968–968. 88 indexed citations

19.

Antonova, Evgeniya & David Zimmerman. (2011). Scope and Severity Index: A Metric for Quantifying Nursing Home Survey Deficiency Number, Scope, and Severity Adjusted for the State-Related Measurement Bias. Journal of the American Medical Directors Association. 13(2). 188.e7–188.e12. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact